Skip to main content
Log in

Possible Interaction between Phenobarbital, Carbamazepine and Itraconazole

  • Case Report
  • Drug Experience
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

We report a case of a possible interaction between itraconazole, phenobarbital and carbamazepine. The first plasma itraconazole concentration, measured when the patient had been taking phenobarbital for 2 months, was very low. The second measurement, 2 months after withdrawing phenobarbital, was higher but below the therapeutic range. However, carbamazepine, a well known enzyme inducer, had been initiated 15 days before. 20 days after carbamazepine was withdrawn, the itraconazole concentration 4 hours after administration was near the lower end of the therapeutic range. The mechanism of this possible interaction is probably the same for phenobarbital and carbamazepine, involving hepatic microsomal enzyme system induction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Blomley M, Teare EL, De Belder A, Thway Y, Weston M. Itraconazole and antituberculosis drugs. Lancet 336: 1255, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bowdle TA, Levy RH, Cutles RE. Effects of carbamazepine on valproic acid in normal man. Clinical Pharmacology and Therapeutics 26: 629–634, 1979

    PubMed  CAS  Google Scholar 

  • Cohen J. Laboratory monitoring of antifungal chemotherapy. Lancet 337: 1577–1580, 1991

    Google Scholar 

  • Dupont B, Drouhet E. Early experience with itraconazole in vitro and in patients: pharmacokinetics studies and clinical results. Reviews of Infectious Diseases 9(Suppl. 1): 71–76, 1987

    Article  Google Scholar 

  • Grant SM, Clissold SP. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 37: 310–344, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hansen JM, Siersback-Nielsen K, Skovsted L. Carbamazepine induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clinical Pharmacology and Therapeutics 12: 539–543, 1971

    PubMed  CAS  Google Scholar 

  • Hay RJ, Clayton YM, Moore MK, Midgely G. An evaluation of itraconazole in the management of onychomycosis. British Journal of Dermatology 119: 359–366, 1988

    Article  PubMed  CAS  Google Scholar 

  • Kramer MR. Cyclosporine and itraconazole interaction in heart and lung transplant recipients. Annals of Internal Medicine 113: 327–329, 1990

    PubMed  CAS  Google Scholar 

  • Lai AA, Levy RH, Cutler RE. Time course of interaction between carbamazepine and clonazepam in normal man. Clinical Pharmacology and Therapeutics 25: 316–323, 1978

    Google Scholar 

  • Lyman CA, Walsh TJ. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic application. Drugs 44: 9–35, 1992

    Article  PubMed  CAS  Google Scholar 

  • Yeh J, Soo SC, Summerton C, Richardson C. Potentiation of action of warfarin by itraconazole. British Medical Journal 301: 669, 1990

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonay, M., Jonville-Bera, A.P., Diot, P. et al. Possible Interaction between Phenobarbital, Carbamazepine and Itraconazole. Drug-Safety 9, 309–311 (1993). https://doi.org/10.2165/00002018-199309040-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199309040-00008

Keywords

Navigation